HC Wainwright & Co. Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $14
HC Wainwright & Co. analyst Douglas Tsao initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Buy rating and announces Price Target of $14.
SVB Leerink Initiates Coverage On Roivant Sciences with Outperform Rating, Announces Price Target of $11
SVB Leerink analyst Geoffrey Porges initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Outperform rating and announces Price Target of $11.
61 Biggest Movers From Yesterday
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the development 1,040 ART systems in Spain and Portugal.
40 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Wallbox N.V. (NYSE: WBX) shares climbed 54.5% to $17.16. Uber and Wallbox N.V. disclosed a strategic partnership to simplify the transition to EVs for Bay Area ride share drivers using Uber.
Jefferies Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $10
Jefferies analyst Dennis Ding initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Buy rating and announces Price Target of $10.
Cowen & Co. Initiates Coverage On Roivant Sciences with Outperform Rating
Cowen & Co. analyst Yaron Werber initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Outperform rating.
Truist Securities Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $15
Truist Securities analyst Robyn Karnauskas initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Buy rating and announces Price Target of $15.